KMT2A oncoproteins induce epigenetic resistance to targeted therapies.
Janssens DH, Duran M, Otto DJ, Kirkey D, Yi JS, Meshinchi S, Sarthy JF, Ahmad K, Henikoff S.
Janssens DH, et al. Among authors: yi js.
bioRxiv [Preprint]. 2023 Dec 30:2023.12.29.573681. doi: 10.1101/2023.12.29.573681.
bioRxiv. 2023.
PMID: 38234854
Free PMC article.
Preprint.